{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:35:33Z","timestamp":1760132133946,"version":"3.37.3"},"reference-count":30,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1124\/dmd.110.034231","type":"journal-article","created":{"date-parts":[[2010,6,26]],"date-time":"2010-06-26T00:42:09Z","timestamp":1277512929000},"page":"1828-1835","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Characterization of Inhibitory Effect of Carbapenem Antibiotics on the Deconjugation of Valproic Acid Glucuronide"],"prefix":"10.1016","volume":"38","author":[{"given":"Yusuke","family":"Masuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kousei","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehito","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Hisaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Honma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.110.034231_bib1","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s002280000211","article-title":"Steady-state dispositions of valproate and diflunisal alone and coadministered to healthy volunteers","volume":"56","author":"Addison","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/dmd.110.034231_bib2","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1212\/WNL.48.1.182","article-title":"Safety and efficacy of divalproex sodium monotherapy in partial epilepsy: a double-blind, concentration-response design clinical trial. Depakote Monotherapy for Partial Seizures Study Group","volume":"48","author":"Beydoun","year":"1997","journal-title":"Neurology"},{"key":"10.1124\/dmd.110.034231_bib3","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0022-3565(25)12214-3","article-title":"Potent and selective inactivation of human liver microsomal cytochrome P-450 isoforms by L-754,394, an investigational human immune deficiency virus protease inhibitor","volume":"275","author":"Chiba","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.110.034231_bib4","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s00134-005-2695-0","article-title":"Pharmacokinetic interaction between valproic acid and meropenem","volume":"31","author":"Clause","year":"2005","journal-title":"Intensive Care Med"},{"key":"10.1124\/dmd.110.034231_bib5","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1345\/aph.1E358","article-title":"Acute seizures due to a probable interaction between valproic acid and meropenem","volume":"39","author":"Coves-Orts","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1124\/dmd.110.034231_bib6","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1177\/0091270009334377","article-title":"Valproic acid plasma concentration decreases in a dose-independent manner following administration of meropenem: a retrospective study","volume":"49","author":"Haroutiunian","year":"2009","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/dmd.110.034231_bib7","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.tox.2006.02.004","article-title":"Absence of convulsive liability of doripenem, a new carbapenem antibiotic, in comparison with \u03b2-lactam antibiotics","volume":"222","author":"Horiuchi","year":"2006","journal-title":"Toxicology"},{"key":"10.1124\/dmd.110.034231_bib8","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0031-6997(24)01372-3","article-title":"Prediction of pharmacokinetic alterations caused by drug-drug interactions: metabolic interaction in the liver","volume":"50","author":"Ito","year":"1998","journal-title":"Pharmacol Rev"},{"key":"10.1124\/dmd.110.034231_bib9","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/rcm.981","article-title":"Method development for the concentration determination of a protein in human plasma utilizing 96-well solid-phase extraction and liquid chromatography\/tandem mass spectrometric detection","volume":"17","author":"Ji","year":"2003","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1124\/dmd.110.034231_bib10","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1128\/AAC.42.12.3136","article-title":"Possible mechanism by which the carbapenem antibiotic panipenem decreases the concentration of valproic acid in plasma in rats","volume":"42","author":"Kojima","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/dmd.110.034231_bib11","doi-asserted-by":"crossref","first-page":"15802","DOI":"10.1016\/S0021-9258(17)36329-9","article-title":"Egasyn, a protein which determines the subcellular distribution of \u03b2-glucuronidase, has esterase activity","volume":"260","author":"Medda","year":"1985","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.110.034231_bib12","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1248\/jhs.53.302","article-title":"In vitro activation of valproate glucuronidation by carbapenem antibiotics","author":"Mori","year":"2007","journal-title":"J Health Sci"},{"key":"10.1124\/dmd.110.034231_bib13","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/jac\/39.2.295","article-title":"Decrease in serum levels of valproic acid during treatment with a new carbapenem, panipenem\/betamipron","volume":"39","author":"Nagai","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1124\/dmd.110.034231_bib14","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1124\/dmd.104.000661","article-title":"Mechanism of the drug interaction between valproic acid and carbapenem antibiotics in monkeys and rats","volume":"32","author":"Nakajima","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.110.034231_bib15","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2174\/187231208786734049","article-title":"Decreased valproate level caused by VPA-glucuronidase inhibition by carbapenem antibiotics","volume":"2","author":"Nakamura","year":"2008","journal-title":"Drug Metab Lett"},{"key":"10.1124\/dmd.110.034231_bib16","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.eplepsyres.2006.05.016","article-title":"Interaction of valproic acid and carbapenem antibiotics with multidrug resistance-associated proteins in rat erythrocyte membranes","volume":"71","author":"Ogawa","year":"2006","journal-title":"Epilepsy Res"},{"key":"10.1124\/dmd.110.034231_bib17","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1211\/jpp.60.9.0009","article-title":"Effect of the \u03b2-glucuronidase inhibitor saccharolactone on glucuronidation by human tissue microsomes and recombinant UDP-glucuronosyltransferases","volume":"60","author":"Oleson","year":"2008","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/dmd.110.034231_bib18","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/jps.20338","article-title":"Increased erythrocyte distribution of valproic acid in pharmacokinetic interaction with carbapenem antibiotics in rat and human","volume":"94","author":"Omoda","year":"2005","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.110.034231_bib19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2710.2005.00671.x","article-title":"Valproate: a simple chemical with so much to offer","volume":"30","author":"Peterson","year":"2005","journal-title":"J Clin Pharm Ther"},{"key":"10.1124\/dmd.110.034231_bib20","doi-asserted-by":"crossref","first-page":"12193","DOI":"10.1016\/S0021-9258(19)50325-8","article-title":"The role of glycosylation and phosphorylation in the expression of active human beta-glucuronidase","volume":"268","author":"Shipley","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.110.034231_bib21","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/00498259509061847","article-title":"Age-dependent intestinal hydrolysis of valproate glucuronide in rat","volume":"25","author":"Slattum","year":"1995","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.110.034231_bib22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2146\/ajhp050512","article-title":"Meropenem-valproic acid interaction in patients with cefepime-associated status epilepticus","volume":"64","author":"Spriet","year":"2007","journal-title":"Am J Health Syst Pharm"},{"key":"10.1124\/dmd.110.034231_bib23","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0378-5173(01)00916-4","article-title":"Carbapenem antibiotics inhibit valproic acid transport in Caco-2 cell monolayers","volume":"233","author":"Torii","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1124\/dmd.110.034231_bib24","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1211\/0022357011776171","article-title":"Inhibition by carbapenem antibiotic imipenem of intestinal absorption of valproic acid in rats","volume":"53","author":"Torii","year":"2001","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/dmd.110.034231_bib25","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1080\/00498250701670945","article-title":"Mechanism-based inactivation of human cytochrome P450 enzymes: strategies for diagnosis and drug-drug interaction risk assessment","volume":"37","author":"Venkatakrishnan","year":"2007","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.110.034231_bib26","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/0006-2952(92)90239-F","article-title":"Studies on the reactivity of acyl glucuronides\u2014III. Glucuronide-derived adducts of valproic acid and plasma protein and anti-adduct antibodies in humans","volume":"43","author":"Williams","year":"1992","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.110.034231_bib27","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/00007691-199808000-00008","article-title":"Panipenem-betamipron and decreases in serum valproic acid concentration","volume":"20","author":"Yamagata","year":"1998","journal-title":"Ther Drug Monit"},{"key":"10.1124\/dmd.110.034231_bib28","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0090-9556(24)15311-1","article-title":"Panipenem, a carbapenem antibiotic, enhances the glucuronidation of intravenously administered valproic acid in rats","volume":"27","author":"Yamamura","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.110.034231_bib29","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/S0090-9556(24)13678-1","article-title":"Panipenum, a carbapenem antibiotic, increases the level of hepatic UDP-glucuronic acid in rats","volume":"28","author":"Yamamura","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.110.034231_bib30","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1248\/bpb1978.4.879","article-title":"A pharmacokinetic analysis program (MULTI) for microcomputer","volume":"4","author":"Yamaoka","year":"1981","journal-title":"J Pharmacobiodyn"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009095562402508X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009095562402508X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.110.034231","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T16:52:31Z","timestamp":1739897551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009095562402508X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S009095562402508X"],"URL":"https:\/\/doi.org\/10.1124\/dmd.110.034231","relation":{},"ISSN":["0090-9556"],"issn-type":[{"type":"print","value":"0090-9556"}],"subject":[],"published":{"date-parts":[[2010,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of Inhibitory Effect of Carbapenem Antibiotics on the Deconjugation of Valproic Acid Glucuronide","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.110.034231","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2010 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}